Cluster headache and kynurenines

Area of Science:

• Neuroscience
• Biochemistry
• Metabolomics

Background:

• Glutamatergic neurotransmission is implicated in primary headache disorders.
• Tryptophan (Trp) metabolism, specifically kynurenine pathway metabolites, influences glutamatergic processes, neuroinflammation, oxidative stress, and mitochondrial function.
• Previous findings indicated altered Trp metabolism in migraineurs, prompting investigation in cluster headache (CH).

Purpose of the Study:

• To compare Trp metabolism compound concentrations in headache-free (interbout) and attack (ictal) periods of CH patients versus healthy controls.
• To investigate correlations between Trp metabolism and clinical features of CH.
• To identify specific alterations in Trp metabolism associated with CH pathophysiology.

Main Methods:

• Neurochemical analysis of 11 molecules in peripheral blood plasma.
• Comparison of metabolite levels between healthy controls (n=22) and CH patients during interbout (n=24) and ictal periods.
• Statistical analysis, including correlation and linear regression, to assess relationships between metabolites and clinical data.

Main Results:

• CH patients showed significantly decreased L-kynurenine (KYN) and increased quinolinic acid (QUINA) in the interbout period compared to controls.
• KYN levels were further reduced during the ictal period.
• Negative correlations were observed between disease duration and interbout QUINA, and between lifetime CH attacks and interbout KYN.

Conclusions:

• CH is characterized by a distinct alteration in Trp metabolism, particularly evident in the interbout period.
• Reduced KYN and elevated QUINA levels may contribute to CH pathogenesis by impairing protective functions and increasing neurotoxicity.
• These metabolic changes could be linked to glutamate-induced neurotoxicity, neuroinflammation, and oxidative stress, potentially serving as therapeutic targets or biomarkers.